Overview
Dongxin Lin practices in Beijing, China. Lin is rated as a Distinguished expert by MediFind in the treatment of Esophageal Cancer. Their top areas of expertise are Esophageal Cancer, Lung Cancer, Pancreatic Cancer, and Lung Adenocarcinoma.
Their clinical research consists of co-authoring 252 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 50 articles in the study of Esophageal Cancer.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Esophageal CancerLin isDistinguished. Learn about Esophageal Cancer.
- Advanced
- Lung AdenocarcinomaLin isAdvanced. Learn about Lung Adenocarcinoma.
- Lung CancerLin isAdvanced. Learn about Lung Cancer.
- Pancreatic CancerLin isAdvanced. Learn about Pancreatic Cancer.
- Experienced
- Colorectal CancerLin isExperienced. Learn about Colorectal Cancer.
- DiarrheaLin isExperienced. Learn about Diarrhea.
- EGFR Positive Lung CancerLin isExperienced. Learn about EGFR Positive Lung Cancer.
- Liver CancerLin isExperienced. Learn about Liver Cancer.
- Methicillin-Resistant Staphylococcus Aureus (MRSA)
- MosaicismLin isExperienced. Learn about Mosaicism.